Patient preferences for reducing bowel adverse events following prostate radiotherapy.

BACKGROUND:The Extended Prostate Cancer Index Composite (EPIC) instrument is a commonly used patient reported outcome (PRO) tool in prostate cancer clinical trials. Summary scores for EPIC subscales are calculated by averaging patient scores for attributes (e.g., side effects), implying equal weight...

Full description

Bibliographic Details
Main Authors: Mark V Mishra, Winter Maxwell Thayer, Ellen Janssen, Bradford Hoppe, Caitlin Eggleston, John F P Bridges
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0235616
id doaj-8b96d4b5b4d24ffd865ff0dcab284acf
record_format Article
spelling doaj-8b96d4b5b4d24ffd865ff0dcab284acf2021-03-03T21:55:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01157e023561610.1371/journal.pone.0235616Patient preferences for reducing bowel adverse events following prostate radiotherapy.Mark V MishraWinter Maxwell ThayerEllen JanssenBradford HoppeCaitlin EgglestonJohn F P BridgesBACKGROUND:The Extended Prostate Cancer Index Composite (EPIC) instrument is a commonly used patient reported outcome (PRO) tool in prostate cancer clinical trials. Summary scores for EPIC subscales are calculated by averaging patient scores for attributes (e.g., side effects), implying equal weighting of the attributes in the absence of evidence showing otherwise. METHODS:We estimated patient preferences for each of the attributes included in the bowel subscale of the EPIC instrument using best-worst (B-W) scaling among a cohort of men with prostate cancer. Patients were presented with multiple tasks in which they were asked to indicate which attribute they would find most and least bothersome at different levels of severity. Analysis utilized both (simple) B-W counts and scores to estimate patient preferences for each attribute as well as attribute levels. RESULTS:A total of 174 respondents from two institutions participated in the survey. Preference estimates for each of the five attributes included in the EPIC-26 bowel subscale showed wide variation preferences: 'losing control of bowel movements' was found to be the most bothersome attribute, with a B-W score of -0.48, followed by bowel urgency which also had negative B-W score (-0.04). Increased frequency of bowel movements was the least bothersome attribute, with a B-W score of +0.33, followed by bloody stools (+0.12), and pelvic/rectal pain (+0.06). Analysis of preference weights for attribute bother levels showed preference estimates be linear. CONCLUSIONS:We provide novel evidence on patient preferences for side effect reduction following prostate radiotherapy. Within the bowel sub-scale of the EPIC-26 short form, we found that bowel incontinence was perceived to be the most bothersome treatment effect, while increased bowel frequency was least bothersome to patients.https://doi.org/10.1371/journal.pone.0235616
collection DOAJ
language English
format Article
sources DOAJ
author Mark V Mishra
Winter Maxwell Thayer
Ellen Janssen
Bradford Hoppe
Caitlin Eggleston
John F P Bridges
spellingShingle Mark V Mishra
Winter Maxwell Thayer
Ellen Janssen
Bradford Hoppe
Caitlin Eggleston
John F P Bridges
Patient preferences for reducing bowel adverse events following prostate radiotherapy.
PLoS ONE
author_facet Mark V Mishra
Winter Maxwell Thayer
Ellen Janssen
Bradford Hoppe
Caitlin Eggleston
John F P Bridges
author_sort Mark V Mishra
title Patient preferences for reducing bowel adverse events following prostate radiotherapy.
title_short Patient preferences for reducing bowel adverse events following prostate radiotherapy.
title_full Patient preferences for reducing bowel adverse events following prostate radiotherapy.
title_fullStr Patient preferences for reducing bowel adverse events following prostate radiotherapy.
title_full_unstemmed Patient preferences for reducing bowel adverse events following prostate radiotherapy.
title_sort patient preferences for reducing bowel adverse events following prostate radiotherapy.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description BACKGROUND:The Extended Prostate Cancer Index Composite (EPIC) instrument is a commonly used patient reported outcome (PRO) tool in prostate cancer clinical trials. Summary scores for EPIC subscales are calculated by averaging patient scores for attributes (e.g., side effects), implying equal weighting of the attributes in the absence of evidence showing otherwise. METHODS:We estimated patient preferences for each of the attributes included in the bowel subscale of the EPIC instrument using best-worst (B-W) scaling among a cohort of men with prostate cancer. Patients were presented with multiple tasks in which they were asked to indicate which attribute they would find most and least bothersome at different levels of severity. Analysis utilized both (simple) B-W counts and scores to estimate patient preferences for each attribute as well as attribute levels. RESULTS:A total of 174 respondents from two institutions participated in the survey. Preference estimates for each of the five attributes included in the EPIC-26 bowel subscale showed wide variation preferences: 'losing control of bowel movements' was found to be the most bothersome attribute, with a B-W score of -0.48, followed by bowel urgency which also had negative B-W score (-0.04). Increased frequency of bowel movements was the least bothersome attribute, with a B-W score of +0.33, followed by bloody stools (+0.12), and pelvic/rectal pain (+0.06). Analysis of preference weights for attribute bother levels showed preference estimates be linear. CONCLUSIONS:We provide novel evidence on patient preferences for side effect reduction following prostate radiotherapy. Within the bowel sub-scale of the EPIC-26 short form, we found that bowel incontinence was perceived to be the most bothersome treatment effect, while increased bowel frequency was least bothersome to patients.
url https://doi.org/10.1371/journal.pone.0235616
work_keys_str_mv AT markvmishra patientpreferencesforreducingboweladverseeventsfollowingprostateradiotherapy
AT wintermaxwellthayer patientpreferencesforreducingboweladverseeventsfollowingprostateradiotherapy
AT ellenjanssen patientpreferencesforreducingboweladverseeventsfollowingprostateradiotherapy
AT bradfordhoppe patientpreferencesforreducingboweladverseeventsfollowingprostateradiotherapy
AT caitlineggleston patientpreferencesforreducingboweladverseeventsfollowingprostateradiotherapy
AT johnfpbridges patientpreferencesforreducingboweladverseeventsfollowingprostateradiotherapy
_version_ 1714814330919190528